Sickle Cell Anemia
Abstract
Sickle cell anemia (SCA) is a disease caused by production of abnormal hemoglobin, which binds with other abnormal hemoglobin molecules within the red blood cell to cause rigid deformation of the cell. This deformation impairs the ability of the cell to pass through small vascular channels; sludging and congestion of vascular beds may result, followed by tissue ischemia and infarction. Infarction is common throughout the body in the patient with SCA, and it is responsible for the earliest clinical manifestation, the acute pain crisis, which is thought to result from marrow infarction. Over time, such insults result in medullary bone infarcts and epiphyseal osteonecrosis. In the brain, white matter and gray matter infarcts are seen, causing cognitive impairment and functional neurologic deficits. The lungs are also commonly affected, with infarcts, emboli (from marrow infarcts and fat necrosis), and a markedly increased propensity for pneumonia. The liver, spleen, and kidney may experience infarction as well. An unusual but life-threatening complication of SCA is sequestration syndrome, wherein a considerable amount of the intravascular volume is sequestered in an organ (usually the spleen), causing vascular collapse; its pathogenesis is unknown. Finally, because the red blood cells are abnormal, they are removed from the circulation, resulting in a hemolytic anemia. For the patient with SCA, however, the ischemic complications of the disease far outweigh the anemia in clinical importance.
References
- 1 Bookchin RM, Lew VL. Pathophysiology of sickle cell anemia. Hematol Oncol Clin North Am 1996; 10:1241-1253.
- 2 Ballas SK. Sickle cell disease: clinical management. Baillieres Clin Haematol 1998; 11:185-214.
- 3 Herrick JB. Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. Arch Intern Med 1910; 6:517-521.
- 4 Pauling L, Itano HA, Singer SJ, Wells IC. Sickle-cell anemia: a molecular disease. Science 1949; 110:543-549.
- 5 Lane PA. Sickle cell disease. Pediatr Clin North Am 1996; 43:639-664.
- 6 Davis CJ, Mostofi FK, Sesterhenn IA. Renal medullary carcinoma: the seventh sickle cell nephropathy. Am J Surg Pathol 1995; 19:1-11.
- 7 Aluoch JR. Higher resistance to Plasmodium falciparum infection in patients with homozygous sickle cell disease in western Kenya. N Engl J Med 1997; 317:781-787.
- 8 Bowman JE, Murray RFJ. Genetic variation in peoples of African origin Baltimore, Md: Johns Hopkins University Press, 1990; 196-201.
- 9 Wethers DL. Sickle cell disease in childhood. I. Laboratory diagnosis, pathophysiology, and health maintenance. Am Fam Phys 2000; 62:1013-1020.
- 10 Bunn HF. Induction of fetal hemoglobin in sickle cell disease. Blood 1999; 93:1787-1789.
- 11 Rodgers GP. Overview of pathophysiology and rationale for treatment of sickle cell anemia. Semin Hematol 1997; 34:2-7.
- 12 Ballas SK, Mohandas N. Pathophysiology of vaso-occlusion. Hematol Oncol Clin North Am 1996; 10:1221-1239.
- 13 Mosseri M, Bartlett-Pandite AN, Wenc K, Isner MH, Weinstein R. Inhibition of endothelium-dependent vasorelaxation by sickle erythrocytes. Am Heart J 1993; 126:338-346.
- 14 Hebbel RP, Vercelotti GM. The endothelial biology of sickle cell disease. J Lab Clin Med 1997; 129:288-293.
- 15 Yaster M, Kost-Byerly S, Maxwell LG. The management of pain in sickle cell disease. Pediatr Clin North Am 2000; 47:699-710.
- 16 Vichinsky EP, Styles LA, Colangelo LH, Wright EC, Castro O, Nickerson B. Acute chest syndrome in sickle cell disease: clinical presentation and course—Cooperative Study of Sickle Cell Disease. Blood 1997; 89:1787-1792.
- 17 Stark P, Pfeiffer WR. Intrathoracic manifestations of sickle cell disease. Radiology 1985; 25:33-35.
- 18 Atkins BL, Price EH, Tillyer L, Novelli V, Evans J. Salmonella osteomyelitis in sickle cell disease children in the east end of London. J Infect 1997; 34:133-138.
- 19 Leong CS, Stark P. Thoracic manifestations of sickle cell disease. J Thorac Imaging 1998; 13:128-134.
- 20 Delatte SJ, Hebra A, Tagge EP, Jackson S, Jacques K, Othersen HB. Acute chest syndrome in the postoperative sickle cell patient. J Pediatr Surg 1999; 34:188-191.
- 21 Martin L, Buonomo C. Acute chest syndrome of sickle cell disease: radiographic and clinical analysis of 70 cases. Pediatr Radiol 1997; 27:637-641.
- 22 Quinn CT, Buchanan GR. The acute chest syndrome of sickle cell disease. J Pediatr 1999; 135:416-422.
- 23 Godeau B, Schaeffer A, Bachir D, et al. Bronchoalveolar lavage in adult sickle cell patients with acute chest syndrome: value for diagnostic assessment of fat embolism. Am J Respir Crit Care Med 1996; 153:1691-1696.
- 24 Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease: National Acute Chest Syndrome Study Group. N Engl J Med 2000; 342:1855-1865.
- 25 Quinn CT, Buchanan GR. The acute chest syndrome of sickle cell disease. J Pediatr 1999; 135:416-422.
- 26 Gelfand MJ, Daya SA, Rucknagel DL, Kalinyak KA, Paltiel HJ. Simultaneous occurrence of rib infarction and pulmonary infiltrates in sickle cell disease patients with acute chest syndrome. J Nucl Med 1993; 34:614-618.
- 27 Bhalla M, Abboud MR, McLoud TC, et al. Acute chest syndrome in sickle cell disease: CT evidence of microvascular occlusion. Radiology 1993; 187:45-49.
- 28 Steinberg B. Sickle cell anemia. Arch Pathol 1930; 9:876-897.
- 29 Lisbona R, Derbekyan V, Novales-Diaz JA. Scintigraphic evidence of pulmonary vascular occlusion in sickle cell disease. J Nucl Med 1997; 38:1151-1153.
- 30 Aldrich TK, Dhuper SK, Patwa NS, et al. Pulmonary entrapment of sickle cells: the role of regional alveolar hypoxia. J Appl Physiol 1996; 80:531-539.
- 31 Pelidis MA, Kato GJ, Resar LM, et al. Successful treatment of life-threatening acute chest syndrome of sickle cell disease with venovenous extracorporeal membrane oxygenation. J Pediatr Hematol Oncol 1997; 19:459-461.
- 32 Trant CA, Casey JR, Hansell D, et al. Successful use of extracorporeal membrane oxygenation in the treatment of acute chest syndrome in a child with severe sickle cell anemia. ASAIO J 1996; 42:236-239.
- 33 Powars D, Weidman J, Odom-Maryon T, Niland JC, Johnson C. Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine 1988; 67:66-76.
- 34 Aquino SL, Gamsu G, Fahy JV, et al. Chronic pulmonary disorders in sickle cell disease: findings at thin-section CT. Radiology 1994; 193:807-811.
- 35 Leong MA, Dampier C, Varlotta L, Allen JL. Airway hyperreactivity in children with sickle cell disease. J Pediatr 1997; 131:278-283.
- 36 Deely DM, Schweitzer ME. MR imaging of bone marrow disorders. Radiol Clin North Am 1997; 35:193-212.
- 37 Anand AJ, Glatt AE. Salmonella osteomyelitis and arthritis in sickle cell disease. Semin Arthritis Rheum 1994; 24:211-221.
- 38 Smith JA. Bone disorders in sickle cell disease. Hematol Oncol Clin North Am 1996; 10:1345-1356.
- 39 Keeley K, Buchanan GR. Acute infarction of long bones in children with sickle cell anemia. J Pediatr 1982; 101:170-175.
- 40 Ware HE, Brooks AP, Toye R, Berney SI. Sickle cell disease and silent avascular necrosis of the hip. J Bone Joint Surg Br 1991; 73:947-949.
- 41 Resnick D, Niwayama G. Osteonecrosis: diagnostic techniques, specific situations, and complications. In: Resnick , eds. Diagnosis of bone and joint disorders. 3rd ed. Philadelphia, Pa: Saunders, 1995; 3495-3515.
- 42 Frush DP, Heyneman LE, Ware RE, Bissett GS. MR features of soft-tissue abnormalities due to acute marrow infarction in five children with sickle cell disease. AJR Am J Roentgenol 1999; 173:989-993.
- 43 Marlow TJ, Brunson CY, Jackson S, Schabel SI. “Tower vertebra”: a new observation in sickle cell disease. Skeletal Radiol 1998; 27:195-198.
- 44 Styles LA, Vichinsky EP. Core decompression in avascular necrosis of the hip in sickle-cell disease. Am J Hematol 1996; 52:103-107.
- 45 Weinberg AG, Currarino G. Sickle cell dactylitis: histopathologic observations. Am J Clin Pathol 1972; 58:518-523.
- 46 Babhulkar SS, Pande K, Babhulkar S. The hand-foot syndrome in sickle-cell haemoglobinopathy. J Bone Joint Surg Br 1995; 77:310-312.
- 47 Stark JE, Glasier CM, Blasier RD, Aronson J, Seibert JJ. Osteomyelitis in children with sickle cell disease: early diagnosis with contrast-enhanced CT. Radiology 1991; 179:731-733.
- 48 Burnett MW, Bass JW, Cook BA. Etiology of osteomyelitis complicating sickle cell disease. Pediatrics 1998; 101:296-297.
- 49 Overturf GD. Infections and immunizations of children with sickle cell disease. Adv Pediatr Infect Dis 1999; 14:191-218.
- 50 Bonnerot V, Sebag G, de Montalembert M, et al. Gadolinium-DOTA enhanced MRI of painful osseous crises in children with sickle cell anemia. Pediatr Radiol 1994; 24:92-95.
- 51 Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998; 339:5-11.
- 52 Preul MC, Cendes F, Just N, Mohr G. Intracranial aneurysms and sickle cell anemia: multiplicity and propensity for the vertebrobasilar territory. Neurosurgery 1998; 42:971-977.
- 53 Moran CJ, Siegel MJ, DeBaun MR. Sickle cell disease: imaging of cerebrovascular complications. Radiology 1998; 206:311-321.
- 54 Schaefer PW, Budzik RF, Koroshetz W, Gonzalez RG. Comparison of diffusion MR imaging, routine MR imaging, and CT in hyperacute stroke. Presented at the 35th Annual Meeting of the American Society of Neuroradiology, Toronto, May 18–22, 1997. ; :.
- 55 Steen RG, Reddick WE, Mulhern RK, et al. Quantitative MRI of the brain in children with sickle cell disease reveals abnormalities unseen by conventional MRI. J Magn Reson Imaging 1998; 8:535-543.
- 56 Steen RG, Langston JW, Ogg RJ, Xiong X, Ye Z, Wang WC. Diffuse T1 reduction in gray matter of sickle cell disease patients: evidence of selective vulnerability to damage? Magn Reson Imaging 1999; 17:503-515.
- 57 Steen RG, Xiong X, Mulhern RK, Langston JW, Wang WC. Subtle brain abnormalities in children with sickle cell disease: relationship to blood hematocrit. Ann Neurol 1999; 45:279-286.
- 58 Adams RJ, McKie VC, Carl EM, et al. Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol 1997; 42:699-704.
- 59 Seibert JJ, Glasier CM, Kirby RS, et al. Transcranial Doppler, MRA, and MRI as a screening examination for cerebrovascular disease in patients with sickle cell anemia: an 8-year study. Pediatr Radiol 1998; 28:138-142.
- 60 Seibert JJ, Miller SF, Kirby RS, et al. Cerebrovascular disease in symptomatic and asymptomatic patients with sickle cell anemia: screening with duplex transcranial Doppler US—correlation with MR imaging and MR angiography. Radiology 1993; 189:457-466.
- 61 Adams RJ, Nichols FT, Figueroa R, McKie V, Lott T. Transcranial Doppler correlation with cerebral angiography in sickle cell disease. Stroke 1992; 23:1073-1077.
- 62 Kogutt MS, Goldwag SS, Gupta KL, Kaneko K, Humbert JR. Correlation of transcranial Doppler ultrasonography with MRI and MRA in the evaluation of sickle cell disease patients with prior stroke. Pediatr Radiol 1994; 24:204-206.
- 63 Verlhac S, Bernaudin F, Tortrat D, et al. Detection of cerebrovascular disease in patients with sickle cell disease using transcranial Doppler sonography: correlation with MRI, MRA, and conventional angiography. Pediatr Radiol 1995; 25(suppl 1):S14-S19.
- 64 Drew JM, Scott JA, Chua GT. General case of the day. RadioGraphics 1993; 13:483-484.
- 65 Levin TL, Berdon WE, Haller JO, Ruzal-Shapiro C, Hurlet-Jenson A. Intrasplenic masses of “preserved” functioning splenic tissue in sickle cell disease: correlation of imaging findings (CT, ultrasound, MRI, and nuclear scintigraphy). Pediatr Radiol 1996; 26:646-649.
- 66 Campbell PJ, Olatunji PO, Ryan KE, Davies SC. Splenic regrowth in sickle cell anaemia following hypertransfusion. Br J Haematol 1997; 96:77-79.
- 67 Roshkow JE, Sanders LM. Acute splenic sequestration crisis in two adults with sickle cell disease: US, CT, and MR imaging findings. Radiology 1990; 177:723-725.
- 68 Schmitt F, Martinez F, Brillet G, et al. Early glomerular dysfunction in patients with sickle cell anemia. Am J Kidney Dis 1998; 32:208-214.
- 69 Wigfall DR, Ware RE, Burchinal MR, Kinney TR, Foreman JW. Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease. J Pediatr 2000; 136:749-753.
- 70 Pham PT, Pham PC, Wilkinson AH, Lew SQ. Renal abnormalities in sickle cell disease. Kidney Int 2000; 57:1-8.
- 71 Saborio P, Scheinman JI. Sickle cell nephropathy. J Am Soc Nephrol 1999; 10:187-192.
- 72 Walker TM, Beardsall K, Thomas PW, Serjeant GR. Renal length in sickle cell disease: observations from a cohort study. Clin Nephrol 1996; 46:384-388.
- 73 Minkin SD, Oh AS, Sanders RC. Urologic manifestations of sickle hemoglobinopathies. South Med J 1979; 72:23-28.
- 74 Walker TM, Searjeant GR. Increased renal reflectivity in sickle cell disease: prevalence and characteristics. Clin Radiol 1995; 195:566-569.
- 75 Harrow BR, Sloane JA, Liebman NC. Roentgenologic demonstration of renal papillary necrosis in sickle cell trait. N Engl J Med 1963; 268:969-976.
- 76 Charlotte F, Bachir D, Nenert M, et al. Vascular lesions of the liver in sickle cell disease: a clinicopathological study in 26 living patients. Arch Pathol Lab Med 1995; 119:46-52.
- 77 Krauss JS, Freant LJ, Lee JR. Gastrointestinal pathology in sickle cell disease. Ann Clin Lab Sci 1998; 28:19-23.
- 78 Hillaire S, Gardin C, Attar A, et al. Cholangiopathy and intrahepatic stones in sickle cell disease: coincidence or ischemic cholangiopathy? Am J Gastroenterol 2000; 95:300-301.
- 79 Al-Salem AH, Qaisruddin S. The significance of biliary sludge in children with sickle cell disease. Pediatr Surg Int 1998; 13:14-16.
- 80 Levin TL, Sheth SS, Hurlet A, et al. MR marrow signs of iron overload in transfusion-dependent patients with sickle cell disease. Pediatr Radiol 1995; 25:614-619.
- 81 Siegelman ES, Outwater E, Hanau CA, et al. Abdominal iron distribution in sickle cell disease: MR findings in transfusion and nontransfusion dependent patients. J Comput Assist Tomogr 1994; 18:63-67.
- 82 Gilkeson RC, Basile V, Sands MJ, Hsu JT. Chest case of the day: extramedullary hematopoiesis (EMH). AJR Am J Roentgenol 1997; 169:270-273.
- 83 James TN, Riddick L, Massing GK. Sickle cells and sudden death: morphologic abnormalities of the cardiac conduction system. J Lab Clin Med 1994; 124:507-520.
- 84 Covitz W, Espeland M, Gallagher D, Hellenbrand W, Leff S, Talner N. The heart in sickle cell anemia: the Cooperative Study of Sickle Cell Disease (CSSCD). Chest 1995; 108:1214-1219.
- 85 Acar P, Sebahoun S, de Pontual L, Maunoury C. Myocardial perfusion in children with sickle cell anaemia. Pediatr Radiol 2000; 30:352-354.
- 86 Fine LC, Petrovic V, Irvine AR, Bhisitkul RB. Spontaneous central retinal artery occlusion in hemoglobin sickle cell disease. Am J Ophthalmol 2000; 129:680-681.
- 87 Charache S. Eye disease in sickling disorders. Hematol Oncol Clin North Am 1996; 10:1357-1362.
- 88 Curran EL, Fleming JC, Rice K, Wang WC. Orbital compression syndrome in sickle cell disease. Ophthalmology 1997; 104:1610-1615.
- 89 Resar LM, Oliva MM, Casella JF. Skull infarction and epidural hematomas in a patient with sickle cell anemia. J Pediatr Hematol Oncol 1996; 18:413-415.
- 90 MacDonald CB, Bauer PW, Cox LC, McMahon L. Otologic findings in a pediatric cohort with sickle cell disease. Int J Pediatr Otorhinolaryngol 1999; 47:23-28.
- 91 Mantadakis E, Cavender JD, Rogers ZR, Ewalt DH, Buchanan GR. Prevalence of priapism in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol 1999; 21:518-522.
- 92 Powars DR, Johnson CS. Priapism. Hematol Oncol Clin North Am 1996; 10:1363-1372.
- 93 Gofrit ON, Rund D, Shapiro A, Pappo O, Landau EH, Pode D. Segmental testicular infarction due to sickle cell disease. J Urol 1998; 160:835-836.
- 94 Antal P, Gauderer M, Koshy M, Berman B. Is the incidence of appendicitis reduced in patients with sickle cell disease? Pediatrics 1998; 101:98-99.
- 95 King KE, Ness PM. Treating anemia. Hematol Oncol Clin North Am 1996; 10:1305-1320.
- 96 Buchanan GR, Bowman WP, Smith SJ. Recurrent cerebral ischemia during hypertransfusion therapy in sickle cell anemia. J Pediatr 1983; 103:921-923.
- 97 Adams RJ. Stroke prevention in sickle cell disease. Curr Opin Hematol 2000; 7:101-105.
- 98 Steinberg MH. Management of sickle cell disease. N Engl J Med 1999; 340:1021-1030.
- 99 Kelly P, Kurtzberg J, Vichinsky E, Lubin B. Umbilical cord blood stem cells: application for the treatment of patients with hemoglobinopathies. J Pediatr 1997; 130:695-703.
- 100 Castro O. Management of sickle cell disease: recent advances and controversies. Br J Haematol 1999; 107:2-11.
- 101 Charache S. Mechanism of action of hydroxyurea. Semin Hematol 1997; 34:15-21.
- 102 Vichinsky EP. Hydroxyurea in children: present and future. Semin Hematol 1997; 34:22-29.
- 103 Koren A, Segal-Kupershmit D, Zalman L, et al. Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia. Pediatr Hematol Oncol 1999; 16:221-232.
- 104 Serjeant GR. Natural history and determinants of clinical severity of sickle cell disease. Curr Opin Hematol 1995; 2:103-108.
- 105 Gill FM, Sleeper LA, Weiner SJ, et al. Clinical events in the first decade in a cohort of infants with sickle cell disease: Cooperative Study of Sickle Cell Disease. Blood 1995; 86:776-783.
- 106 Miller ST, Sleeper LA, Pegelow CH, et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 2000; 342:83-89.
- 107 Davis H, Schoendorf KC, Gergen PJ, Moore RM, Jr. National trends in the mortality of children with sickle cell disease: 1968 through 1992. Am J Public Health 1997; 87:1317-1322.
Article History
Published in print: July 2001